Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

Autor: Bardymova, Tatiana, Barrientos Perez, Margarita, Bethin, Kathleen, Bjornstad, Petter, Bondar, Irina, Chen, Mimi, Choi, Jin-Ho, Clements, Mark A, Colomar, Javier Ricardo, Daniels, Mark, Deerochanawong, Chaicharn, Desai, Vivek S, Desmangles, Jean-Claude G, Dillon, Robert G, Dixit, Naznin M, Du, Hongwei, Edelen, Rachel, Espinoza Peralta, Diego, Felipe Gacioppo, María Verónica, Ferraz, Tania Maria Bulcão Lousada, Galkina, Galina, Gallagher, Mary Patricia, George, Minu, Gonzalez, Edgar, Gottschalk, Michael Everett, Guido, Giancarlo, Hassan, Amir Ali, Hershkovitz, Eli, Huerta-Saenz, Lina P, Hwang, Jin Soon, Ibarra Gomez, Jaime Orlando, Irizarry Gonzalez, Lydia, Jain, Nina, Jelley, David H, Kim, Ho-Seong, Kovalenko, Tatiana, Laffel, Lori Michelle B, Leichter, Steven B, Liberatore Jr, Raphael Del Roio, Lynch, Jane, Mahmud, Farid Hussain, Malievskiy, Oleg Arturovich, Muir, Andrew, Nelson, Bryce A, Nevarez Ruiz, Luis Alejandro, Olson, Micah L, Pelayo Orozco, Emilia Susana, Peterkova, Valentina, Ramírez Mendoza, Fernando Ramón, Reddy, Konda Mohan, Rodriguez, Henry, Saenz, Javier Andres, Samoilova, Julia, Schwab, Karl-Otfried, Shah, Sejal H, Shehadeh, Naim, Shoemaker, Ashley H, Skorodok, Yulia, Sobolev, Aleksandr, Solís, Silvana Ernestina, Srinivasan, Shylaja, Tamborlane, William V, Tsalikian, Eva, Valeeva, Farida, Vance, Carl D, Velasquez-Mieyer, Pedro A, Violante Ortiz, Rafael Margarito, Votyakova, Olga, Wei, Haiyan, Weinstock, Ruth S, Wheeler, Mark D, Wicklow, Brandy Alexandra, Willi, Steven M, Wintergerst, Kupper A, Wolf, Risa M, Wood, Jamie Ruth, Yaliwal, Chandan, Yupanqui Lozno, Hernán, Laffel, Lori M ^*, Danne, Thomas, Klingensmith, Georgeanna J, Willi, Steven, Zeitler, Philip, Neubacher, Dietmar, Marquard, Jan

Publikováno v: In The Lancet Diabetes & Endocrinology March 2023 11(3):169-181

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

FGF1ΔHBS delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis

Autor: Lin, Qian, Chen, Oscar, Wise, John P., Jr, Shi, HongXue, Wintergerst, Kupper A., Cai, Lu, Tan, Yi

Publikováno v: In BBA - Molecular Basis of Disease 1 August 2022 1868(8)

Long-Term Neurobehavioral and Quality of Life Outcomes of Critically Ill Children after Glycemic Control

Autor: Srinivasan, Vijay, Mourani, Peter M., Chima, Ranjit, Thomas, Neal J., Li, Simon, Pinto, Alan, Newth, Christopher, Hassinger, Amanda, Bysani, Kris, Rehder, Kyle J., Faustino, Edward Vincent, Kandil, Sarah, Hirshberg, Eliotte, Wintergerst, Kupper, Schwarz, Adam, Bagdure, Dayanand, Marsillio, Lauren, Cvijanovich, Natalie, Pham, Nga, Quasney, Michael, Flori, Heidi, Federman, Myke, Nett, Sholeen, Pinto, Neethi, Viteri, Shirley, Schneider, James, Medar, Shivanand, Sapru, Anil, McQuillen, Patrick, Babbitt, Christopher, Lin, John C., Jouvet, Philippe, Yanay, Ofer, Allen, Christine, Asaro, Lisa, Coughlin-Wells, Kerry, French, Jaclyn, Natarajan, Aruna, Biagas, Katherine V., Hinton, Veronica J., Hasbani, Natalie R., Luckett, Peter M., Wypij, David, Nadkarni, Vinay M., Agus, Michael S.D.

Publikováno v: In The Journal of Pediatrics March 2020 218:57-63

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.